Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-23-025559

President and CEO sold 29,766 shares at $2.04 ($60,633)

From the SEC's structured data for this filing

Trades in this filing

Touchon Pascal · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-05-16 Sale : show line 1 in the form −29,766 $2.04 $60,633 720,962 D
Open-market sales · 29,766 sh · avg $2.04 · $60,633
Loading xslF345X04/form4.xml…